Sigma Automate has emerged from stealth with $2.75 million in funding led by Glasswing Ventures to introduce its AI-native, no-code IT automation platform. The platform helps enterprise IT teams automate complex workflows across hybrid cloud, on-premise, and virtual desktop environments without needing coding skills, addressing a growing market need as organizations adopt hybrid cloud strategies. Sigma Automate's technology reduces downtime and improves security by enabling autonomous self-healing, patch management, and compliance enforcement. The company has already gained traction with Fortune 1000 and mid-market customers in industries like retail, logistics, and healthcare, positioning itself as a solution to the IT skills gap and operational complexity challenges.
Investment banks Scotiabank and Bernstein have lowered their price targets for Comcast due to increased competition from new players like SpaceX's Starlink and valuation risks. Comcast is also undergoing a major strategic shift by spinning off its NB...
Elevance Health reported strong Q2 2026 results with earnings per share of $7.45, surpassing analyst estimates of around $6.20. Revenue also exceeded expectations at $49.83 billion, marking consistent quarterly outperformance. The company raised its ...
Lotto.com has appointed Ruxandra Tereanu as Chief Operating Officer and Amanda Coyle as Vice President of Human Resources to strengthen its leadership team amid ongoing expansion in the US digital lottery market. Tereanu brings 13 years of experience...
Worldline has announced a conference call to discuss its H1 2026 financial results on July 30, 2026, at 6:30 pm CET. The event will be accessible via webcast, and sell-side analysts can participate in a Q&A session by pre-registering. The press relea...
Ipsen Pharma conducted a share buy-back program from July 6 to July 10, 2026, repurchasing a total of 28,541 shares. The average purchase price during this period was €166.05 per share. This buy-back activity reflects Ipsen's strategy to manage its c...
